Autophagy: Molecular mechanisms and overview

Autophagy is a complex process by which dysfunctional cellular components are degraded inside the cell through the action of lysosomes. Here we review the key stages and processes involved in this pathway and the role of autophagy in different diseases.

​​Autophagy is a tightly regulated pathway with a vital housekeeping role, allowing cells to eliminate damaged or harmful components through catabolism and recycle them to maintain nutrient and energy homeostasis. Autophagy is also a major protective mechanism, which helps cell survival in response to multiple stress conditions, such as nutrient or growth factor deprivation, hypoxia, reactive oxygen species (ROS), DNA damage, or intracellular pathogens1.

Autophagy is a dynamic process present in all cells at low levels under basal conditions, but stimuli, such as nutrient starvation or hypoxia, can lead to its upregulation.

Autophagy process technical image

Autophagy interactive pathway

PDF

Download
secondary-primary
none

What to expect

The interactive pathway highlights protein interactions in various autophagy stages, such as initiation, nucleation, expansion, maturation, fusion, and degradation. It also helps you quickly find the best products for your target of interest by reading the pop-ups and product tables that include Abcam's full product offering.

Initiation and phagophore formation

The molecular mechanism of autophagy involves several conserved Atg (a u t opha g y-related) proteins. Various stimuli, such as nutrient starvation, lead to the formation of the phagophore, a step that involves two protein complexes:

Phagophore elongation and autophagosome formation (or nucleation, expansion, and maturation)

The elongation of the phagophore results in the formation of the characteristic double-membrane autophagosome. This step requires two ubiquitin-like conjugation pathways, both catalyzed by Atg7.

Processed LC3-II is recruited onto the growing phagophore and its integration is dependent on Atg5-Atg12. Unlike Atg5-Atg12-Atg16L, LC3-II is found on both the inner and outer surfaces of the autophagosome, where it is required for the expansion and completion of the autophagic membrane. After the closure of the autophagosomal membrane, the Atg16-Atg5-Atg12 complex dissociates from the vesicle, whereas a portion of LC3-II remains covalently bound to the membrane (Figure 1). Therefore, LC3-II can be used as a marker to monitor the level of autophagy in cells.

It has been postulated that various organelles, including mitochondria, the Golgi complex, and the endoplasmic reticulum (ER), can be the origin of the autophagosomal membrane5. Recent studies demonstrate that the self-multimerization of Atg9 may facilitate membrane tethering and/or fusion6.

Fusion, degradation, and recycling

When the autophagosome formation is completed, LC3-II attached to the outer membrane is cleaved from PE by Atg4 and released back to the cytosol. The fusion between the autophagosome and the lysosome is thought to require the lysosomal membrane protein LAMP-1 and the small GTPase Rab7.

After fusion, a series of acid hydrolases are involved in the degradation of the sequestered cytoplasmic cargo. The small molecules resulting from the degradation, particularly amino acids, are transported back to the cytosol for protein synthesis and maintenance of cellular functions under starvation conditions. The identification of Atg22 together with other vacuolar permeases (such as Avt3 and Avt4) as vacuolar amino acid effluxers during yeast autophagy has helped in the understanding of the mechanisms of nutrient recycling7. These permeases represent the last step in the degradation and recycling process7.

Types of autophagy

There are currently three types of autophagy in mammalian cells3:

Macroautophagy:

Macroautophagy is the main autophagic pathway and it is characterized by the delivery of cytoplasmic cargo to the lysosome through an intermediary double membrane-bound vesicle, known as an autophagosome, which fuses with the lysosome to form an autolysosome.

Microautophagy:

Microautophagy involves the direct engulfment of cytoplasmic cargo into the lysosome through the invagination of the lysosomal membrane. Microautophagy is important in the maintenance of organellar size, membrane homeostasis, and cell survival under nitrogen restriction8.

Chaperone-mediated autophagy (CMA):

Chaperone-mediated autophagy (CMA) involves the direct translocation of cytoplasmic proteins across the lysosomal membrane in a complex with chaperone proteins that are recognized by the lysosomal membrane receptor LAMP-2A (lysosomal-associated membrane protein 2A), resulting in their unfolding and degradation.

Autophagy in disease

Autophagy has been widely implicated in many pathophysiological processes, including cancer, metabolic and neurodegenerative disorders, cardiovascular and pulmonary diseases. It also has an important role in aging and exercise9.

Autophagy in cancer

Autophagy was first linked to cancer through the role of Beclin 1, which is essential for the autophagy pathway and has been mapped to tumor susceptibility10. Since then, multiple tumor-suppressor proteins have been identified that are involved in the control of the autophagy pathway (eg p53, Bcl2, PTEN, etc).

​​​The tumor cells exploit the autophagic mechanism to provide a way for them to overcome nutrient-limiting conditions and facilitate tumor growth. Studies show that autophagy can modulate the tumor microenvironment by promoting angiogenesis, supply nutrients, and modulate inflammatory response11.

Autophagy in neurodegenerative diseases

Neurodegenerative diseases are characterized by the accumulation of mutant or toxic proteins12,13. It has been shown that the autophagic pathway helps in cell survival by removing unwanted cellular organelle and protein aggregates. Disruption of autophagy-specific genes in neural cells leads to neurodegeneration14,15.

Autophagy in cardiovascular diseases

The autophagic pathway is essential for normal maintenance, repair, and adaptation of the heart tissue. Unsurprisingly, therefore, autophagic deficiencies have been associated with a variety of cardiac pathologies16.

Autophagy in infectious disease

Autophagy plays a key role in immune defense against invading bacteria and pathogens. Upon infection, autophagy regulates inflammation, antigen presentation, and micro-organism capture and degradation17.

References

  1. Levine, B. & , Kroemer, G. Autophagy in the pathogenesis of disease. Cell  11 ,27-42 (2008)
  2. Mizushima, N. Mizushima, N. Autophagy: process and function. Genes Dev  21 ,2861-2873 (2007)
  3. Glick, D., , Barth, S., &, Macleod, K.F. Autophagy: cellular and molecular mechanisms. J. Pathol.  221 ,3-12 (2010)
  4. Kaur, J. &, Debnath, J. Autophagy at the crossroads of catabolism and anabolism. Nat. Rev. Mol. Cell Biol.  16 ,461-472 (2015)
  5. Wei, Y.,, Liu, M., , Li, X.,, Liu, J.,, & Li, H. Origin of the autophagosome membrane in mammals. 2018:1012789 (2018). Biomed Res Int.  2018 ,1012789 (2018)
  6. He, C., , Baba, M.,, Cao, Y., , & Klionsky, D.J. Self-interaction is critical for Atg9 transport and function at the phagophore assembly site during autophagy. Mol. Biol. Cell.  19 ,5506-5516 (2008)
  7. Yang, Z., , Huang, J., , Geng, J.,, Nair, U., & , Klionsky, D.J. Atg22 recycles amino acids to link the degradative and recycling functions of autophagy. Mol Biol Cell.  17 , 5094-5104 (2006)
  8. Li, W.W.,, Li, J. & , Bao, J.K. Microautophagy: lesser-known self-eating. Cell Mol. Life Sci.,  69 ,1125-1136 (2012)
  9. Choi, A.M., , Ryter, S.W. &, Levine, B. Autophagy in human health and disease. N. Engl. J. Med.  368, ,1845-1846 (2013)
  10. Liang, X.H., et al. Induction of autophagy and inhibition of tumorigenesis by Beclin 1. Nature  402 ,672-676 (1999)
  11. Yang, X. et al. The role of autophagy induced by tumor microenvironment in different cells and stages of cancer. Cell Biosci  5 ,14 (2015)
  12. Ravikumar, B., , Duden, R., & , Rubinsztein, D.C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet.  11 ,1107-1117 (2002)
  13. Ravikumar B., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet.  36 ,585-595 (2004)
  14. Komatsu, M., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature  441 ,880-884 (2006)
  15. Hara, T. et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature  441 ,885-889 (2006)
  16. Cuervo, A. M. Autophagy: in sickness and in health. Trends Cell Bio.  14 ,70-77 (2004)
  17. Levine, B., , Mizushima, N., & , Virgin, H.W. Autophagy in immunity and inflammation. Nature  469 ,323-335 (2011)